Ceo may still have “skin in the game” but selling 20% of your holding at a discount just before significant releases from the company does not bode well in anyone’s language!
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025